Please provide your email address to receive an email when new articles are posted on . GLP-1s were linked to lower rates of hospitalization and mortality in IBD. Patients with ulcerative colitis and ...

Billions of dollars in U.S. biosimilar erosion to AbbVie’s blockbuster immunology drug Humira is no match for its rising superstar Skyrizi. Despite the fall of what was once the world’s top-selling ...

Caldera Therapeutics has burst onto the scene with $112.5 million in combined series A cash the Massachusetts biotech will use to fund development of an inflammatory bowel disease (IBD) drug licensed ...

Inflammatory bowel disease (IBD) is a crowded drug market with plenty of treatment options across the two forms of the gastrointestinal disease: ulcerative colitis and Crohn’s disease. But one ...

Inflammatory bowel disease (IBD), which causes inflammation in the digestive tract, may complicate other health concerns as patients age. To address the specific challenges faced by older adults with ...

When examining the risk based on IBD subgroups, the data showed a significant increase in IBD-related hospitalizations among patients with Crohn disease, though a similar result was not seen in those ...

If you’re recovering from surgery for inflammatory bowel disease (IBD) — which includes Crohn’s disease and ulcerative colitis — you’ve probably got questions about what you can (and should) eat. The ...

Roche’s Genentech unit has handed over $20 million in upfront cash for the license to Omass Therapeutics’ preclinical inflammatory bowel disease (IBD) program. The program is the product of Omass’ ...

Hong Xu receives funding from the Swedish Research Council (Starting grant#2022-01428) and the Center for Innovative Medicine Foundation (CIMED, FoUI-1002840). Jonas F. Ludvigsson has coordinated an ...

Patients with inflammatory bowel disease (IBD) had a significantly higher risk for developing interstitial lung disease (ILD) compared with the general population and siblings who do not have the ...

The American College of Gastroenterology has released a 2025 update to its clinical guideline on preventive care in IBD, replacing the previous 2017 version, Medscape reported July 14. This revised ...